BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 27381341)

  • 1. Prediction of 14-year cardiovascular outcomes by dobutamine stress
    Roest S; Boiten HJ; van Domburg RT; Valkema R; Schinkel AFL
    J Nucl Cardiol; 2018 Feb; 25(1):63-71. PubMed ID: 27381341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing.
    Schinkel AF; Elhendy A; Biagini E; van Domburg RT; Valkema R; Rizello V; Pedone C; Simoons M; Bax JJ; Poldermans D
    J Nucl Med; 2005 Jan; 46(1):12-8. PubMed ID: 15632027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac stress imaging for the prediction of very long-term outcomes: Dobutamine stress echocardiography or dobutamine
    Boiten HJ; van Domburg RT; Geleijnse ML; Valkema R; Zijlstra F; Schinkel AFL
    J Nucl Cardiol; 2018 Apr; 25(2):471-479. PubMed ID: 27444501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of long-term (> 10 year) cardiovascular outcomes in heart transplant recipients: Value of stress technetium-99m tetrofosmin myocardial perfusion imaging.
    Veenis JF; Boiten HJ; van den Berge JC; Caliskan K; Maat APWM; Valkema R; Constantinescu AA; Manintveld OC; Zijlstra F; van Domburg RT; Schinkel AFL
    J Nucl Cardiol; 2019 Jun; 26(3):845-852. PubMed ID: 29116562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography.
    Boiten HJ; van der Sijde JN; Ruitinga PR; Valkema R; Geleijnse ML; Sijbrands EJ; van Domburg RT; Schinkel AF
    J Nucl Cardiol; 2012 Oct; 19(5):907-13. PubMed ID: 22875719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eleven-year prognostic value of dobutamine stress (99m)Tc-sestamibi myocardial perfusion imaging in patients with limited exercise capacity.
    Boiten HJ; van Domburg RT; Valkema R; Schinkel AF
    Am J Cardiol; 2015 Apr; 115(7):884-9. PubMed ID: 25661571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of 14-year outcomes in patients with a limited exercise capacity: Utility of dobutamine myocardial perfusion imaging in a high-risk population.
    Veenis JF; Valkema R; van Domburg RT; Schinkel AF
    J Nucl Cardiol; 2015 Oct; 22(5):888-900. PubMed ID: 25537614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of 8-year cardiovascular outcomes in patients with systemic arterial hypertension: value of stress (99m)Tc-tetrofosmin myocardial perfusion imaging in a high-risk cohort.
    Wai MC; Ottenhof MJ; Boiten HJ; Valkema R; van Domburg RT; Schinkel AF
    J Nucl Cardiol; 2013 Dec; 20(6):1030-40. PubMed ID: 24132813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the value of stress (99m)Tc-tetrofosmin myocardial perfusion imaging for the assessment of very long-term outcome in obese patients?
    Korbee RS; Boiten HJ; Ottenhof M; Valkema R; van Domburg RT; Schinkel AF
    J Nucl Cardiol; 2013 Apr; 20(2):227-33. PubMed ID: 23188629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events.
    Schinkel AF; Elhendy A; van Domburg RT; Bax JJ; Vourvouri EC; Bountioukos M; Rizzello V; Agricola E; Valkema R; Roelandt JR; Poldermans D
    Am J Cardiol; 2003 Feb; 91(4):408-11. PubMed ID: 12586253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of dobutamine-atropine stress (99m)Tc-tetrofosmin myocardial perfusion SPECT in patients with known or suspected coronary artery disease.
    Schinkel AF; Elhendy A; van Domburg RT; Bax JJ; Roelandt JR; Poldermans D
    J Nucl Med; 2002 Jun; 43(6):767-72. PubMed ID: 12050321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification among diabetic patients undergoing stress myocardial perfusion imaging.
    Ghatak A; Padala S; Katten DM; Polk DM; Heller GV
    J Nucl Cardiol; 2013 Aug; 20(4):529-38. PubMed ID: 23703380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dobutamine stress myocardial perfusion imaging: 8-year outcomes in patients with diabetes mellitus.
    Boiten HJ; van Domburg RT; Valkema R; Zijlstra F; Schinkel AF
    Eur Heart J Cardiovasc Imaging; 2016 Aug; 17(8):871-6. PubMed ID: 26792936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography.
    Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Poldermans D
    J Nucl Cardiol; 2003; 10(6):615-22. PubMed ID: 14668773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognostic value of Tc-99m tetrofosmin myocardial gated-SPECT imaging in asymptomatic patients after percutaneous coronary intervention.
    Georgoulias P; Demakopoulos N; Tzavara C; Giannakou S; Valotassiou V; Tsougos I; Xaplanteris P; Fezoulidis I
    Clin Nucl Med; 2008 Nov; 33(11):743-7. PubMed ID: 18936603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental prognostic value of dobutamine-atropine stress 99mTc-tetrofosmin myocardial perfusion imaging for predicting outcome in diabetic patients with limited exercise capacity.
    Pedone C; Schinkel AF; Elhendy A; van Domburg RT; Valkema R; Biagini E; Simoons ML; Bax JJ; Poldermans D
    Eur J Nucl Med Mol Imaging; 2005 Sep; 32(9):1057-63. PubMed ID: 15864583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of stress Tc-99m tetrofosmin SPECT in patients with previous myocardial infarction: impact of scintigraphic extent of coronary artery disease.
    Elhendy A; Schinkel AF; van Domburg RT; Bax JJ; Valkema R; Poldermans D
    J Nucl Cardiol; 2004; 11(6):704-9. PubMed ID: 15592194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognostic value of exercise 99mTc-MIBI SPET myocardial perfusion imaging in patients after percutaneous coronary intervention.
    Zhang X; Liu X; He ZX; Shi R; Yang M; Gao R; Chen J; Yang Y; Fang W
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):655-62. PubMed ID: 14740177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental prognostic value of (99m)Tc-tetrofosmin myocardial SPECT after percutaneous coronary intervention.
    Georgoulias P; Tzavara C; Demakopoulos N; Giannakou S; Valotassiou V; Tsougos I; Xaplanteris P; Fezoulidis I
    Ann Nucl Med; 2008 Dec; 22(10):899-909. PubMed ID: 19142709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of 99mTc-tetrofosmin SPECT myocardial perfusion imaging on the prediction of future adverse cardiac events.
    Jain D; Lessig H; Patel R; Sandler L; Weiland F; Edell SL; Elizabeth Oates M; O'Malley-Tysko E; Khutoryansky N; Jacobson AF
    J Nucl Cardiol; 2009; 16(4):540-8. PubMed ID: 19396504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.